The Use of Complementary and Alternative Medicine for Liver Disease

Abstract

Get full access to this article

View all access options for this article.

References

Andrade

Lucena

Fernandez

. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology. 2005;129:512-521.

Russo

Galanko

Shrestha

Fried

Watkins

. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl. 2004;10:1018-1023.

Suk

Kim

. A prospective nationwide study of drug-induced liver injury in Korea. Am J Gastroenterol. 2012;107:1380-1387.

Teschke

Wolff

Frenzel

Schulze

Eickhoff

. Herbalife® hepatotoxicity: a tabular compilation of reported cases. Liver Int. 2012;32(10): 1543-1556.

Hsu

Huang

Tsay

Chang

Lee

. Acute hepatitis induced by Chinese hepatoprotective herb, xiao-chai-hu-tang. J Chin Med Assoc. 2006;69:86-88.

Kamiyama

Nouchi

Kojima

Murata

Ikeda

Sato

. Autoimmune hepatitis triggered by administration of an herbal medicine. Am J Gastroenterol. 1997;92:703-704.

Hiramatsu

Sakata

Horita

. Mesenteric phlebosclerosis associated with long-term oral intake of geniposide, an ingredient of herbal medicine. Aliment Pharmacol Ther. 2012;36:575-586.

Galloway

Marsh

Bittiner

. Chinese herbs for eczema, the active compound? Lancet. 1991;337:566.

Mazzanti

Menniti-Ippolito

Moro

. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol. 2009;65:331-341.

10.

Seeff

. Herbal hepatotoxicity. Clin Liver Dis. 2007;11:577-596.

11.

Ammon

Kelber

Okpanyi

. Spasmolytic and tonic effect of Iberogast (STW 5) in intestinal smooth muscle. Phytomedicine. 2006;13(suppl 5):114-121.

12.

BenniTeschke

Glass

Schulze

. Herbal hepatotoxicity by greater celandine (Celidonium majus): causality assessment of 22 spontaneous reports. Regul Toxicol Pharmacol. 2011;61(3):282-291.

13.

Brent

. Three new herbal hepatotoxic syndromes. Clin Toxicol. 1999;37(6): 715-719.

14.

Teschke

. Kava hepatotoxicity: pathogenetic aspects and prospective considerations. Liver Int. 2010;30:1270-1279.

15.

Pittler

Edzard

. Kava extract for treating anxiety. Cochrane Database Syst Rev. 2001;(4):CD003383.

16.

Teschke

Schwarzenboeck

Hennermann

K-H

. Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases. Eur J Gastroenterol Hepatol. 2008;20:1182-1193.

17.

Nelson

. Persephone’s seeds: abortifacients and contraceptives in ancient Greek medicine and their recent scientific appraisal. Pharm Hist. 2009;51(2):57-69.

18.

Anderson

Mullen

Meeker

. Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature. Ann Intern Med. 1996;124:726-734.

19.

Lewis

. FDA advises dietary supplement manufacturers to remove comfrey products from the market [letter to industry trade organizations, professional organizations, and nonprofit groups]. July 6, 2001. http://www.cfsan.fda.gov/~dms/dspltr06.html

20.

Chen

Huo

. Hepatic veno-occulsive disease associated with toxicity of pyrrolizidine alkaloids in herbal preparations. Neth J Med. 2010;68(6):252-260.

21.

Herbalife. http://company.herbalife.com/Content/en-US/pdf/about-herbalife/press-room/Herbalife-Corporate-Profile-October-2009.pdf

22.

Jóhannsson

Ormarsdóttir

Olafsson

. Hepatotoxicity associated with Herbalife® products. Laeknabladid. 2010;96(3):167-172.

23.

Appelhans

Smith

Bejar

Henig

. Revisiting acute liver injury associated with Herbalife products. World J Hepatol. 2011;3: 275-277.

24.

Fong

Klontz

Canas-Coto

. Hepatotoxicity due to Hydroxycut: a case series. Am J Gastroenterol. 2010;105:1561-1566.

25.

Stickel

Kessebohm

Weimann

Seitz

. Review of liver injury associated with dietary supplements. Liver Int. 2011;31:595-605.

26.

Cleland

Gross

Koss

Daynard

Muoio

. Federal Trade Commission staff report Sept 2002: weight-loss advertising: an analysis of current trends. http://www.ftc.gov/bcp/reports/weightloss.pdf

27.

McCormack

Keating

. Prolonged-release nicotinic acid: a review of its use in the treatment of dyslipidaemia. Drugs. 2005;65(18): 2719-2740.

28.

Henkin

Johnson

Segrest

. Rechallenge with crystalline niacin after drug-induced hepatitis from sustained-release niacin. JAMA. 1990;264(2):241-243.

29.

Mullin

Greenson

Mitchell

. Fulminant hepatic failure after ingestion of sustained-release nicotinic acid. Ann Intern Med. 1989;111(3):253-255.